• FirefoxInstall the new Firefox »
  •  Dow Down 0.76% Nasdaq Down 0.87%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    3.71 Up 0.14(3.85%) 10:31AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.57
    Open:3.59
    Bid:3.67 x 200
    Ask:3.68 x 500
    1y Target Est:6.50
    Beta:2.24
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:3.58 - 3.71
    52wk Range:1.56 - 4.20
    Volume:276,415
    Avg Vol (3m):890,231
    Market Cap:326.42M
    P/E (ttm):N/A
    EPS (ttm):-1.04
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RIGL

    Comparison

    Symbol% ChgMkt Cap
    RIGLUp 3.85%326.42M
    AMGNDown 2.77%117.95B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):38.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.83
    Quarterly EPS Est (Mar-15) :-0.20
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disord... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback